US STOCK

AXSM Stock Analysis

US stocks · market data · technical indicators

Axsome Therapeutics, Inc.

AXSMUS stocks

Quote delayed 15 min

9/12 上午12:12 updated

$224.20

+13.08+6.20%

Open

$212.71

High

$229.62

Low

$212.44

Volume

46.32萬

AXSM price history

+4.96%

Open

213.68

Latest

224.28

High

224.28

Low

198.52

Average

209.37

AI Composite Technical Analysis

Beta

Buy

Formula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)

AI Score75

Score range 0–100; a higher score indicates a stronger buy signal

Market Status

Buy

Current Price$224.2

Target Price$280.25

Change %+6.20%

Institutional

Net Selling

Foreign Ownership

Reducing

Market Heat

Strong

Fundamentals (US)

P/E Ratio

ROE

-245.10%

P/B Ratio

139.29x

Dividend Yield

Market Insight

The composite score points to a strong buy signal (75/100), with several technical and fundamental indicators in positive territory. Notable price movement today (+6.20%), indicating increased market attention. The target price implies roughly 25.00% upside.

This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.

Financial snapshot

Yahoo Finance

AXSM - Axsome Therapeutics, Inc.

EPS

-3.76USD

Forward EPS

5.03USD

P/E

Forward P/E

44.08x

P/B

139.29x

ROE

-245.10%

ROA

-16.31%

Operating margin

-23.42%

Profit margin

-24.68%

Revenue growth

45.50%

Earnings growth

Dividend yield

Financial statements

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$218.38M	$191.20M	$196.00M	$170.99M	$150.04M
Gross profit	$204.81M	$176.48M	$183.67M	$159.08M	$136.59M
Operating income	-$51.14M	-$62.77M	-$36.02M	-$32.92M	-$44.82M
Net income	-$51.31M	-$64.54M	-$28.56M	-$47.23M	-$47.97M
Basic EPS	-0.99	-1.26	-0.56	-0.94	-0.97
Diluted EPS	-0.99	-1.26	-0.56	-0.94	-0.97

Estimates vs actuals

Next earnings

2026-11-02

EPS estimate

-0.46

Revenue estimate

$258.26M

Last surprise

-26.85%

Date	Estimate	Actual	Surprise
2026-11-02	-0.46	Not reported	—
2026-08-10	-0.78	-0.99	-26.85%
2026-05-04	-0.86	-1.26	-46.03%
2026-02-23	-0.73	-0.56	+23.63%
2025-11-03	-0.90	-0.94	-4.19%
2025-08-04	-1.09	-0.97	+10.75%
2025-05-05	-1.35	-1.22	+9.51%
2025-02-18	-1.05	-1.54	-47.03%
2024-11-12	-1.39	-1.34	+3.49%
2024-08-05	-1.33	-1.67	-25.84%
2024-05-06	-1.22	-1.44	-17.65%
2024-02-20	-1.19	-2.08	-74.83%

Institutional holders

Institution	Quarter	Value held	Portfolio weight
VANGUARD GROUP INC	2025-12-31	$760.7M	0.01%
BlackRock Inc.	2024-06-30	$265.6M	0.01%
STATE STREET CORP	2026-06-30	$192.3M	0.01%
TWO SIGMA INVESTMENTS, LP	2026-06-30	$163.9M	0.12%
RENAISSANCE TECHNOLOGIES LLC	2026-06-30	$64.1M	0.09%
CITADEL ADVISORS LLC	2026-06-30	$62.6M	0.01%
Bridgewater Associates, LP	2026-06-30	$14.2M	0.06%

13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.

Analyst ratings

21 analysts

Mean target

$285.42

Target range

$246.00 – $380.00

Implied upside

28.63%

Strong buy

Buy

Hold

Sell

Strong sell